Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Lobe Sciences Ltd. LOBEF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
43/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lobe Sciences Ltd. (LOBEF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.07. It has a SharesGrow Score of 39/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net income is $4M (loss), growing at +22.5%/yr. Net profit margin is 0% (thin). Gross margin is 98.7% (+1.6 pp trend).

Balance sheet: total debt is $273,163 against $2M equity (Debt-to-Equity (D/E) ratio 0.12, conservative). Current ratio is 3.13 (strong liquidity). Debt-to-assets is 3.6%. Total assets: $8M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 46/100 (Partial), Future ?/100 (Fail), Income ?/100 (Fail).

LOBEF SharesGrow Score Overview

57/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 46/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — LOBEF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
LOBEF: -91.9%/yr revenue is, +22.5%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet LOBEF: Debt-to-Equity (D/E) ratio 0.12 (conservative), Current ratio is 3.13 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
46/100
LOBEF: Gross margin is 98.7% (+1.6 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 46/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.0015-0.047
Volume58.68K
Avg Volume (30D)70.01K
Market Cap$12.77M
Beta (1Y)-0.21
Share Statistics
EPS (TTM)-0.03
Shares Outstanding$138.72M
IPO Date2023-08-24
CEOFrederick Dominick Sancilio
Financial Highlights & Ratios
EBITDA$-4.26M
Net Income$-4.42M
Operating Income$-4.18M
Total Cash$7.54M
Total Debt$273.16K
Net Debt$-5.58M
Total Assets$7.58M
Price / Earnings (P/E)-2.1
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA53946V2066

Price Chart

Track all markets on TradingView
LOBEF
Lobe Sciences Ltd. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.05

People Also View

CWBHF
CWBHF
Charlotte's Web Holdings, Inc.
$0.62
-0.82%
 AAWH
AAWH
Ascend Wellness Holdings, Inc.
$0.47
+2.19%
 MYCOF
MYCOF
Mydecine Innovations Group Inc.
$1.32
+0.00%
 CXXIF
CXXIF
C21 Investments Inc.
$0.31
+15.12%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 TRUFF
TRUFF
Red Light Holland Corp.
$0.02
-6.19%
 HYEX
HYEX
Healthy Extracts Inc.
$1.60
+0.00%
 SILFF
SILFF
Silo Wellness Inc.
$0.01
+166.67%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message